| NCT Number | NCT07321925 |
| Lead Sponsor | Endra Lifesciences |
| Conditions | MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis), Fatty Liver Disease, Nonalcoholic |
| Enrollment | 49 participants |
| Start Date | 2025-08-15 |
| Primary Completion | 2025-10-30 (estimated) |
| Study Completion | 2025-12-31 (estimated) |
| Updated on ClinicalTrials.gov | 2026-01-07 |